Relation between resistin, PPAR-γ, obesity and atherosclerosis in male albino rats

References

• Achike, F.L., et al., 2011. Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint. Clinical and experimental pharmacology and physiology, 38 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Baran, S., et al., 2005. Combination of high fat diet and chronic stress retracts hippocampal dendrites. Neuroreport, 16 (1), 39–43.
   PubMed Web of Science ®Google Scholar
• Bays, H.E., 2009. Sick fat, metabolic disease, and atherosclerosis. The American journal of medicine, 122 (1 Suppl), S26–S37.
   PubMed Web of Science ®Google Scholar
• Bogacka, I., et al., 2004. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes care, 27 (7),1660–1667.
   Web of Science ®Google Scholar
• Bruder-Nascimento, T., et al., 2013. Effects of chronic stress and high-fat diet on metabolic and nutritional parameters in Wistar rats. Arquivos brasileiros de endocrinologia e metabologia, 57 (8),642–649.
   PubMedGoogle Scholar
• Burger, F., et al., 2009. Cannabenoid receptor activation is cardioprotective in mouse model of ischemia/reperfusion. Journal of molecular and cellular cardiology, 46, 612–620.
   Google Scholar
• Chan, I.S.F., et al., 2003. Statistical analysis of non-inferiority trials with a rate ratio in small-sample match –pair designs. Biometrics, 59 (4), 1170–1177.
   PubMed Web of Science ®Google Scholar
• Chang, S., et al., 1990. Metabolic differences between obesity-prone and obesity-resistant rats. American journal of physiology, 259, R1103–R1110.
   PubMedGoogle Scholar
• Cho, Y., et al., 2011. Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. Journal of the American college of cardiology, 57 (1), 99–109.
   PubMed Web of Science ®Google Scholar
• Costandi, J., et al., 2011. Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling. Circulation research, 8,727–742.
   Google Scholar
• Friedewald, W.T., Levy, R.I., and Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18 (6), 499–502.
   PubMed Web of Science ®Google Scholar
• Game, B.A., et al., 2007. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice. Atherosclerosis, 192 (1), 85–91.
   PubMed Web of Science ®Google Scholar
• Garrel, D.R., et al., 1995. Improved clinical status and length of care with low-fat nutrition support in burn patients. Journal of parenteral and enteral nutrition, 19 (6), 482–491.
   PubMed Web of Science ®Google Scholar
• Jamaluddin, M.S., et al., 2012. Resistin: functional roles and therapeutic considerations for cardiovascular disease. British journal of pharmacology, 165 (3), 622–632.
   PubMed Web of Science ®Google Scholar
• Jung, H.S., et al., 2006. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular research, 69 (1), 76–85.
   PubMed Web of Science ®Google Scholar
• Kablak-Ziembicka, A., et al., 2011. Carotid intima-media thickness, hsCRP and TNF-alpha are independent associated with cardiovascular even risk in patients with atherosclerotic occlusive disease. Atherosclerosis, 214 (1), 185–190.
   PubMed Web of Science ®Google Scholar
• Link, J.J., Rohatgi, A., and de Lemos, J.A., 2007. HDL cholesterol physiology, pathophysiology, and management. Current problems in cardiology, 32 (5), 268–314.
   PubMed Web of Science ®Google Scholar
• McTernan, P.G., et al., 2002. Increased resistin gene and protein expression in human abdominal adipose tissue. The journal of clinical endocrinology and metabolism, 87 (5), 2407–2411.
   PubMed Web of Science ®Google Scholar
• Meer, R.W., et al., 2009. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglycerides accumulation and high energy phosphate metabolism in patients with well controlled type 2 diabetes mellitus. Circulation, 119 (15),2069–2077.
   PubMed Web of Science ®Google Scholar
• Mojiminiyi, O.A., and Abdella, N.A., 2007. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scandinavian journal of clinical and laboratory investigation, 67 (2), 215–225.
   PubMed Web of Science ®Google Scholar
• Montecucco, F., et al., 2009. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. Journal of molecular and cellular cardiology, 46 (5), 612–620.
   PubMed Web of Science ®Google Scholar
• Nascimen, H., et al., 2010. Leukocyte count versus C-reactive protein levels in obese Portuguese patients aged 6–12 years old. Open biochemistry journal, 4, 72–76.
   PubMedGoogle Scholar
• National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): National Academies Press.
   Google Scholar
• Ohshima, K., Mogi, M., and Horiuchi, M., 2012. Role of peroxisome proliferator-activated receptor-γ in vascular inflammation. International journal of vascular medicine, 2012, 508416.
   PubMedGoogle Scholar
• Park, C.W., et al., 2006. PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney international, 69 (9),1511–1517.
   Web of Science ®Google Scholar
• Patel, L., et al., 2003. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochemical and biophysical research communications, 300 (2), 472–476.
   PubMed Web of Science ®Google Scholar
• Rajala, M.W., and Scherer, P.E., 2003. Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology, 144 (9), 3765–3773.
   PubMed Web of Science ®Google Scholar
• Rajala, M.W., et al., 2004. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes, 53 (7), 1671–1679.
   PubMed Web of Science ®Google Scholar
• Rucker, J.A., and Crowley, S.D., 2017. The role of macrophages in hypertension and its complications. Pflugers Archiv: European journal of physiology, 469 (3–4), 419–430.
   PubMed Web of Science ®Google Scholar
• Scotece, M., et al., 2012. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators of inflammation, 2012,125458.
   PubMed Web of Science ®Google Scholar
• Shadid, S., and Jensen, M.D., 2003. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes care, 26 (11), 3148–3152.
   PubMed Web of Science ®Google Scholar
• Smith, S.R., et al., 2005. Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. Metabolism, 54 (1), 24–32.
   PubMed Web of Science ®Google Scholar
• Sood, V., and Chakravarti, R.N., 1976. Systemic stress in the production of cardiac thrombosis in hypercholesterolaemic rats. Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie), 167 (1),31–45.
   PubMedGoogle Scholar
• Szapary, P.O., et al., 2006. Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome. Arteriosclerosis, thrombosis, and vascular biology, 26 (1), 182–188.
   PubMed Web of Science ®Google Scholar
• Van de Woestijne, A.P., et al., 2011. Adipose tissue dysfunction and hypertrigly-ceridemia: mechanisms and management. Obesity reviews, 12 (10), 829–840.
   PubMed Web of Science ®Google Scholar
• Van Meel, D., et al., 1992. Differences in risk factors for disease and health problems between monks and the general population in The Netherlands. Ned Tijdschr Geneeskd, 136, 1551–1555.
   PubMedGoogle Scholar
• Wang, C.-Y., and Liao, K.J., 2012. Mouse model of diet-induced obesity and insulin resistance. Methods Mol Biol, 821, 421–433.
   PubMedGoogle Scholar
• Wang, S., et al., 2014. Chronic unpredictable mild stress combined with a high-fat diet aggravates atherosclerosis in rats. Lipids in health and disease, 13 (1),77.
   PubMedGoogle Scholar
• Won, J.C., et al., 2009. Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance. Journal of Korean medical science, 24 (4), 695–700.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, K., Goko, H., and Matsuoka, A., 1979. Effects of electric stress on glucose metabolism, glucosestimulated cyclic adenosine 3′,5′-monophosphate accumulation and 45 Ca+ + efflux in isolated pancreatic islets from rats fed with a high fat diet. Endocrinologia Japonica, 26 (5), 549–557.
   PubMedGoogle Scholar
• Yang, R.Z., et al., 2003. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochemical and biophysical research communications, 310 (3), 927–935.
   PubMed Web of Science ®Google Scholar
• Zou, C.C., et al., 2005. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocrine journal, 52 (5), 519–524.
   PubMed Web of Science ®Google Scholar